Most people still think of lung cancer as a smoker’s disease. The data tell a more nuanced story.
If you set aside every current and former smoker, lung cancer among never-smokers would still rank roughly 7th or 8th among causes of cancer death in the United States— accounting for more than 20,000 deaths each year. That is not a trivial number. It is a primary-prevention opportunity that current guidelines largely ignore.
The U.S. Preventive Services Task Force and American Cancer Society recommend annual low-dose CT (LDCT) screening only for adults aged 50–80 who have a 20+ pack-year smoking history and either still smoke or quit within the past 15 years. Never-smokers fall completely outside those criteria. The recommendation is evidence-based for high-risk smokers—the National Lung Screening Trial (NLST) demonstrated a roughly 20% relative reduction in lung cancer mortality, which translates to approximately one lung cancer death prevented for every 320 high-risk people screened over several years. That is a meaningful absolute benefit in the right population. The same trial (and others) also showed that most of the cancers found by screening were early-stage and therefore more treatable.
Never-smokers sit outside that evidence base. There are no large randomized trials of LDCT specifically in Western never-smokers, so any decision is necessarily individualized and off-guideline. The absolute risk is lower than in heavy smokers, which means the number needed to screen to prevent one death would be higher. At the same time, the absolute mortality numbers remain large, early detection still shifts stage dramatically, and modern LDCT is quick, low-dose, and requires no contrast.
The main trade-offs are well known: the possibility of false positives or indeterminate nodules that require short-interval follow-up, rare invasive procedures, a small cumulative radiation exposure, and the anxiety that can accompany an unexpected finding. These risks are worth discussing candidly.
In many concierge practices we are therefore having more conversations about offering yearly LDCT to never-smokers who have additional risk factors (family history, significant secondhand smoke or radon exposure, or certain ancestry patterns) and who understand the trade-offs. This is not a blanket recommendation. It is a shared decision that weighs risk tolerance against the chance of catching early cancer while minimizing the noise. This should always be personalized!
Happy to walk through the numbers, the pros and cons, and the logistics if this resonates.